 | Your browser does not display parts of our website correctly. We use the latest technology available to provide you with a high quality experience; please upgrade your browser to its latest version to view the contents properly: |
Stockwinners Market Radar for March 30, 2018 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service |
| RDUS | Hot Stocks14:39 EDT Radius Health initiates Phase 3 study of abaloparatide in osteoporosis - Radius Health announced that the company has initiated the Phase 3 Atom study of abaloparatide injection for the treatment of osteoporosis in men. "Approximately 20 percent of men over the age of 50 years will sustain an osteoporotic-related fracture in their lifetime attributed to multiple risk factors. If successful, this study will serve as the basis of a supplemental New Drug Application (sNDA) seeking to expand the use of abaloparatide to treat men with osteoporosis at high risk for fracture," said Gary Hattersley, PhD, Chief Scientific Officer of Radius Health. "The study will also include specialized high-resolution imaging to examine the effect of abaloparatide on bone structure, such as the hip, in a subset of the study participants." The primary endpoint of the male osteoporosis study is change in lumbar spine bone mineral density at 12 months compared with placebo. The randomized, double-blind, placebo-controlled trial will enroll approximately 225 men with osteoporosis. Abaloparatide, marketed as Tymlos, was approved in April 2017 by the FDA for the treatment of postmenopausal women with osteoporosis at high risk for fracture.
|
| CALM | Hot Stocks14:36 EDT Cal-Maine Foods names Sherman Miller President, COO - Cal-Maine Foods announced that the company has named Sherman Miller President and Chief Operating Officer, effective March 30. Miller, currently Vice President and COO, will assume new executive duties in addition to his responsibility for all of Cal-Maine Foods' production and processing facilities.
|
| KO | Hot Stocks14:34 EDT Coca-Cola tells shareholders to reject TRC Capital's mini-tender offer - Coca-Cola said it has learned of an unsolicited mini-tender offer by TRC Capital for the purchase of up to 2.5M shares at $41.50 per share. The stock closed yesterday up 10c to $43.33. "Coca-Cola does not endorse TRC Capital's offer. The Company recommends that shareholders reject the offer and not tender their shares in response because the offer is at a price below the current market price for Coca-Cola shares and is subject to many conditions. TRC Capital's offer price is approximately 4.51 percent below the closing share price of Coca-Cola common stock ($43.46) on March 16, 2018, the day before the offer commenced. The offer is for less than 0.06 percent of Coca-Cola's outstanding shares," Coke announced in a statement. It added, "TRC Capital's offer states that it may terminate or amend the offer if, among other things, the market price of Coca-Cola's stock declines or if TRC Capital fails to obtain financing necessary. Coca-Cola is not associated with TRC Capital or its offer."
|
| UAL | Hot Stocks13:04 EDT DOT tentatively approves United to increase Houston and Havana service - The U.S. Department of Transportation tentatively awarded United Airlines and Mesa Airlines authority to begin offering daily nonstop service between Houston's George Bush Intercontinental Airport and Havana's Jose Marti International Airport. Subject to final government approval, United will expand from Saturday-only service to daily service.
|
| JKS NEE | Hot Stocks13:02 EDT NextEra, JinkoSolar announce supply agreement for solar panels - NextEra Energy (NEE) announced that it is the counterparty to a supply agreement that was announced by JinkoSolar (JKS) in January. The companies amended the agreement this month, and JinkoSolar will supply NextEra Energy with up to 2,750 megawatts of high-efficiency solar modules - roughly 7M solar panels - over approximately four years. In conjunction with this agreement, JinkoSolar is opening its first U.S. factory in Jacksonville, Florida, which is expected to create more than 200 direct jobs in Florida and support hundreds of additional local jobs in shipping and other related industries. Once fully operational, JinkoSolar's factory in Jacksonville is expected to have the capacity to build 400 megawatts of solar modules annually - more than 1M solar panels a year. Production is expected to begin later this year. JinkoSolar anticipates using the Port of Jacksonville for a large volume of importing and exporting activities.
|
| OC | Hot Stocks09:32 EDT Owens Corning names Marcio Sandri as President, Composites - Owens Corning announced today that Marcio Sandri has been named President, Composites, effective May 25. Arnaud Genis has decided to retire after serving as President, Composites for the last seven years, the company said. Sandri currently serves as Vice President, Global Strategy and Operations for the company's Composites business.
|
| ABMD WTS | Hot Stocks09:21 EDT Abiomed appoints Todd Trapp as Chief Financial Officer - Abiomed (ABMD) announced that Todd Trapp will be appointed as Vice President and Chief Financial Officer, effective April 9. Trapp joins Abiomed from Watts Water Technologies (WTS), where he served as CFO since 2015.
|
| DTE | Hot Stocks09:20 EDT DTE Energy submits 2018 Renewable Energy Plan to Michigan - DTE Energy said it has submitted its 2018 Renewable Energy Plan to the Michigan Public Service Commission proposing approximately 1,000 additional megawatts of carbon-free electricity from new wind and solar projects in Michigan scheduled to be completed by 2022. If approved, these new renewable energy projects would drive investment of more than $1.7B in Michigan and double DTE's renewable energy capacity from 1,000 megawatts to 2,000 megawatts - enough clean energy to power over 800,000 homes, the company said. The filing outlines DTE's approach to Michigan's 15% Renewable Portfolio Standard as well as its intent to offer a new voluntary renewable energy program specifically designed for large business customers seeking to reduce carbon emissions, DTE added. T
|
| WTS | Hot Stocks09:18 EDT Watts Water announces resignation of CFO Todd Trapp - Watts Water Technologies announced that Todd Trapp, its Chief Financial Officer, has decided to leave the company on April 6 to pursue a new opportunity. Robert Pagano, the company's President and Chief Executive Officer, will act as CFO on an interim basis while a search for the company's next CFO is being conducted.
|
| LGND | Hot Stocks09:17 EDT Ligand enters OmniAb platform license agreement with venBio Partners - Ligand Pharmaceuticals announces it has entered into an agreement with venBio Partners which permits venBio's portfolio companies to enter into a pre-agreed worldwide OmniAb platform license agreement. Under any platform license agreement, venBio's portfolio companies will be able to use the full OmniAb platform including OmniRat, OmniMouse, OmniFlic and OmniChicken to discover fully human mono- and bispecific antibodies. Ligand is eligible to receive access payments, development and regulatory milestone payments, and tiered royalties for each product incorporating an OmniAb antibody. venBio's future portfolio companies will be responsible for all costs related to the programs. "This deal represents an 'OmniAb first' in terms of enabling a venture investor to incubate a series of new companies with common OmniAb licensing terms, enabling their portfolio companies to focus on drug development and value creation from the start," said John Higgins, CEO of Ligand. "The OmniAb business continues to expand, driven by industry demand for our leading antibody-discovery technology with multiple species and broad freedom-to-operate."
|
| VIPS | Hot Stocks08:22 EDT Vipshop to invest up to $250M in private equity fund - Vipshop Holdings announced that the company has entered into definitive agreements and committed to invest up to $250M into a private equity fund with consumer goods and supply chain as one of its key investment areas. The closing of this investment will be subject to regulatory approval and customary conditions.
|
| GHDX | Hot Stocks08:21 EDT Epic, Genomic announce favorable draft local coverage determination - Epic Sciences and Genomic Health (GHDX) announced that Palmetto GBA, a Medicare Administrative Contractor that assesses molecular diagnostic technologies, has issued a draft local coverage determination for the Oncotype DX AR-V7 Nucleus Detect test. The draft LCD recommends Medicare coverage for use of the test throughout the United States to help determine which patients with metastatic castration-resistant prostate cancer may benefit from androgen receptor signaling inhibitor (ARSi) therapy and which may benefit from chemotherapy, the companies said in a statement. The Oncotype DX AR-V7 Nucleus Detect test is a circulating tumor cell-based, liquid biopsy test that is commercially available in the United States through Epic's partnership with Genomic Health. "Prior to the Oncotype DX AR-V7 Nucleus Detect test, there was no clear consensus on therapeutic sequencing after initial exposure to an ARSi therapy, and the most common clinical decision in mCRPC was whether to start a second ARSi or taxane chemotherapy," Epic and Genomic write. Murali Prahalad, CEO of Epic Sciences, said, "The rapid issuance of the draft LCD recommending Medicare coverage highlights the clinical utility and value of this new test in prolonging survival for men with metastatic castration-resistant prostate cancer."
|
| FMI | Hot Stocks08:17 EDT Foundation Medicine says genomic profiling assay now available in U.S. - Foundation Medicine announced that FoundationOne CDx, the first FDA approved comprehensive genomic profiling assay for all solid tumors incorporating multiple companion diagnostics, is now available in the United States. FoundationOne CDx assesses genomic alterations in 324 genes known to drive cancer growth. "Now that FoundationOne CDx is widely available in the U.S., oncologists can begin using this valuable test to help guide and simplify personalized treatment decisions for their patients," Vincent Miller, Chief Medical Officer at Foundation Medicine. "By integrating FoundationOne CDx early into routine clinical care, oncologists can create treatment efficiencies and expand access to biomarker-driven medicines for patients, with the potential to improve treatment outcomes."
|
| LYB GE | Hot Stocks08:15 EDT LyondellBasell names Jacinth Smiley Chief Accounting Officer - LyondellBasell (LYB) announced it has named Jacinth Smiley its Chief Accounting Officer, effective April 2. Smiley joins LyondellBasell from General Electric Oil & Gas (GE) where she served as chief Financial Officer for the North America region.
|
| RIG | Hot Stocks08:13 EDT Transocean completes acquisition of Songa Offshore SE - Transocean announced that it completed the previously announced compulsory acquisition of the remaining outstanding shares of Songa Offshore SE. All remaining shares in Songa Offshore were transferred to Transocean in accordance with the terms and conditions of the compulsory acquisition. Songa Offshore's shares remained listed on the Oslo Stock Exchange through March 28.
|
| MET TCEHY | Hot Stocks08:12 EDT MetLife, Tencent's WeSure announce strategic partnership - MetLife (MET) and WeSure, digital insurance provider owned by Tencent (TCEHY), announced a strategic partnership to offer insurance solutions to travelers through Tencent's WeSure online insurance platform. "This alliance marries WeSure's extensive base of 1 billion monthly active users on Tencent's mobile social communications platform, WeChat, with MetLife's global expertise in life and health protection solutions, and enables both parties to collaborate in fields such as big-data analysis, tailor-made and intelligent value-added services to deliver easier to use, more transparent end-to-end protection solutions for Chinese travellers," the companies said in a statement. The partnership's first solution is an aviation accident insurance product which will be provided on the WeSure platform.
|
